Literature DB >> 12765746

Body mass index and quality of life in community-dwelling patients with schizophrenia.

Martin Strassnig1, Jaspreet Singh Brar, Rohan Ganguli.   

Abstract

OBJECTIVE: To examine the associations between sociodemographic variables, body weight and quality of life in schizophrenic outpatients.
METHODS: Assessments included an interview to obtain sociodemographic data, administration of a Quality of Life questionnaire (the MOS SF-36) and measurement of height and weight. Body mass index was calculated (kg/m(2)). SF-36 subscores were examined for statistical differences based on BMI categories: healthy weight (BMI<or=24.9), overweight (BMI 25-29.9) and obese (BMI>or=30). Correlations with sociodemographic variables were also examined.
RESULTS: Body weight was inversely correlated (level p<or=0.005) to the SF-36 items: physical functioning (PF, -0.452), role limitations due to physical functioning (-0.279), role limitations due to emotional functioning (-0.256), vitality (-0.200), general health (GH, -0.367) and physical component score (PCS, -0.400). Mental component score (MCS) was not significantly correlated to body weight. When comparing quality of life across BMI categories, obese subjects had worse physical functioning (p<or=0.0005) and general health (p<or=0.005), reported more role limitations due to emotional functioning (p<or=0.05) and a lower physical component score (p<or=0.005). Mental component score was not significantly influenced by BMI.
CONCLUSIONS: Quality of life in schizophrenic patients is related to body weight. The burden of obesity is primarily experienced as a physical problem.

Entities:  

Mesh:

Year:  2003        PMID: 12765746     DOI: 10.1016/s0920-9964(02)00441-3

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  30 in total

Review 1.  Pharmacogenetics of antipsychotic-induced weight gain.

Authors:  Christoph U Correll; Anil K Malhotra
Journal:  Psychopharmacology (Berl)       Date:  2004-07-08       Impact factor: 4.530

2.  Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status.

Authors:  Philip D Harvey; Martin Strassnig
Journal:  World Psychiatry       Date:  2012-06       Impact factor: 49.548

3.  Dietary intake of patients with schizophrenia.

Authors:  Martin Strassnig; Jaspreet Singh Brar; Rohan Ganguli
Journal:  Psychiatry (Edgmont)       Date:  2005-02

4.  Exercise program adherence using a 5-kilometer (5K) event as an achievable goal in people with schizophrenia.

Authors:  Kimberly R Warren; M Patricia Ball; Stephanie Feldman; Fang Liu; Robert P McMahon; Deanna L Kelly
Journal:  Biol Res Nurs       Date:  2010-12-30       Impact factor: 2.522

Review 5.  Interventions to reduce weight gain in schizophrenia.

Authors:  G Faulkner; T Cohn; G Remington
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

6.  Barriers and facilitators of a healthy lifestyle among persons with serious and persistent mental illness: perspectives of community mental health providers.

Authors:  Christine L McKibbin; Katherine A Kitchen; Thomas L Wykes; Aaron A Lee
Journal:  Community Ment Health J       Date:  2014-07

7.  A 12-week weight reduction intervention for overweight individuals taking antipsychotic medications.

Authors:  Carla A Green; Shannon L Janoff; Bobbi Jo H Yarborough; Micah T Yarborough
Journal:  Community Ment Health J       Date:  2014-02-25

8.  Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.

Authors:  Martin Strassnig; Jean Miewald; Matcheri Keshavan; Rohan Ganguli
Journal:  Schizophr Res       Date:  2007-05-02       Impact factor: 4.939

9.  Lack of Association between Glutathione S-Transferase-M1, -T1, and -P1 Polymorphisms and Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients.

Authors:  Young-Min Park; Heon-Jeong Lee; Seung-Gul Kang; Jung-Eun Choi; Jae-Hyuck Cho; Leen Kim
Journal:  Psychiatry Investig       Date:  2010-05-12       Impact factor: 2.505

10.  G-protein beta3 Subunit Gene 825C/T Polymorphism Is Not Associated with Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients.

Authors:  Young-Min Park; Young-Cho Chung; Seung-Hwan Lee; Kang-Joon Lee; Hyun Kim; Jung-Eun Choi; Seung-Gul Kang; Min-Soo Lee; Leen Kim; Heon-Jeong Lee
Journal:  Psychiatry Investig       Date:  2009-03-31       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.